WO2009091050A1 - Composition for oral application - Google Patents

Composition for oral application Download PDF

Info

Publication number
WO2009091050A1
WO2009091050A1 PCT/JP2009/050587 JP2009050587W WO2009091050A1 WO 2009091050 A1 WO2009091050 A1 WO 2009091050A1 JP 2009050587 W JP2009050587 W JP 2009050587W WO 2009091050 A1 WO2009091050 A1 WO 2009091050A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
oral
lactic acid
weight
taste
Prior art date
Application number
PCT/JP2009/050587
Other languages
French (fr)
Japanese (ja)
Inventor
Naomi Yasuda
Original Assignee
Sunstar Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc. filed Critical Sunstar Inc.
Priority to JP2009550070A priority Critical patent/JP5404424B2/en
Publication of WO2009091050A1 publication Critical patent/WO2009091050A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Definitions

  • the present invention relates to an oral composition, and in particular, relates to an oral composition that stably contains lactic acid bacteria and has excellent shape retention and taste.
  • the oral composition may contain various active ingredients in the preparation for the purpose of imparting function and efficacy.
  • the active ingredients include fluoride, bactericidal ingredients, anti-inflammatory ingredients, anticalculus ingredients, hemostasis Agents and the like.
  • lactic acid bacteria, plant extracts, herbal medicines and the like have been incorporated into oral compositions as natural bactericidal and bacteriostatic components that are gentle on the human body and have few side effects.
  • lactic acid bacteria are considered to act as bacteriostatic agents for periodontal disease and periodontal disease by acting in the oral cavity where caries-causing bacteria and periodontal disease-causing bacteria are present. It is attracting attention as an active ingredient gentle to the human body with less adverse effects such as side effects.
  • lactic acid bacteria are easily affected by moisture and chemical substances, and it is difficult to stably mix lactic acid bacteria for a long period of time. From such a point of view, it is conceivable to reduce the water content, but since such oral compositions contain a large amount of organic solvents other than water, in addition to the stability of lactic acid bacteria, bitterness, gummy taste, etc. There are many cases where the taste is difficult.
  • a thickener such as sodium carboxymethylcellulose, carrageenan, or xanthan gum is mainly blended, and these components dissolve in water to develop viscosity, and powder components And liquid components are combined to give shape retention and moderate viscosity.
  • a thickener such as sodium carboxymethylcellulose, carrageenan, or xanthan gum
  • it is difficult to obtain shape retention because the viscosity does not increase even if a thickener is added, and the powder component and liquid component can be separated over time. I get up.
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2002-302429 discloses an oral composition in which bitterness and itchiness are alleviated by using sodium bicarbonate in a non-aqueous oral composition base. Yes.
  • Patent Document 2 Japanese Patent Laid-Open No. 2002-255572
  • Patent Document 3 Japanese Patent Laid-Open No. 2007-23056
  • an oral composition can be obtained.
  • the oral compositions disclosed in these publications are not sufficient in taste and shape retention, and are not described at all when they contain lactic acid bacteria.
  • the spinnability which is important in the use and production stage of the oral composition, has not been clarified.
  • Patent Document 4 Japanese Patent Laid-Open No. 2005-298346 discloses a non-aqueous oral composition containing lactic acid bacteria and / or bifidobacteria and hydroxyapatite
  • Patent Document 5 Japanese Patent Laid-Open No. 2007-131601.
  • Non-aqueous oral compositions containing a specific lactic acid bacterium (S.faecalis) have been disclosed, but none of the composition has been clarified about the taste, and the stability of the lactic acid bacterium is unknown.
  • the present invention is capable of stably blending lactic acid bacteria in a live state, and at the same time, the water content is at least significantly improved in bitterness and savory taste, and has shape retention and suitable stringiness.
  • An object of the present invention is to provide a composition for an oral cavity that also has a composition.
  • the inventors of the present invention can stably mix lactic acid bacteria as viable bacteria if it is an oral composition containing 1,3-butylene glycol and hydroxyethyl cellulose. It has been found that the water content is at least significantly improved in bitterness and taste, and also has shape retention and suitable spinnability.
  • the present invention particularly provides the oral composition according to items 1 to 6 below.
  • Item 1 An oral composition containing lactic acid bacteria, 1,3-butylene glycol and hydroxyethyl cellulose.
  • Item 2. Furthermore, the composition for oral cavity of Claim 1 containing any 1 type or 2 types of wetting agents chosen from the group which consists of propylene glycol and polyethyleneglycol.
  • Item 3. The oral composition according to claim 1 or 2, wherein the total amount of 1,3-butylene glycol and propylene glycol and / or polyethylene glycol is 35% by weight or more.
  • the lactic acid bacterium, 1,3-butylene glycol, propylene glycol and hydroxyethyl cellulose are contained, and 1,3-butylene glycol / propylene glycol (weight ratio) is 1 or more, according to any one of claims 1 to 3.
  • the oral composition according to any one of claims 1 to 5 further comprising at least one surfactant selected from the group consisting of amino acid surfactants, amide betaines, and alkyl glycosides.
  • the present invention it is possible to stably mix lactic acid bacteria as living bacteria, and at the same time, the water content is at least greatly improved in bitterness and gummy taste, and the shape retention and suitable silk thread
  • the composition for oral cavity which also has property can be provided.
  • the oral environment (especially the balance of bacteria in the oral flora) is adjusted and adversely affects the human body such as caries-causing bacteria and periodontal disease-causing bacteria.
  • lactic acid bacteria are natural bacteriostatic components that are gentle on the human body with few side effects, and can stably meet the health-consciousness of recent people by blending stably.
  • composition for oral cavity according to the present application has shape retentivity, it is inconvenient to use as a unit when the used amount is taken out at the time of use, or when placed on a toothbrush. There will be no problems such as sinking in.
  • the oral composition is used in the oral cavity, and whether the taste is good or bad is an important point for consumers. There is no discomfort. Further, there is no inconvenience due to the stringiness during manufacture and use.
  • the oral composition according to the present invention contains lactic acid bacteria, 1,3-butylene glycol and hydroxyethyl cellulose.
  • the lactic acid bacterium blended in the oral composition according to the present invention is not particularly limited as long as the effect of the present invention by the lactic acid bacterium can be achieved, but S.faecium, L.reuteri, L.gasseri, L. salivalius, L. mesenteroides, L. brevis, L. acidophilus, L. brugaricus, L. plantarum and S. faecalis are preferred, and among them, S. faecium, L. gasseri, L. mesenteroides, L. brevis L. acidophilus and S. faecalis are preferred.
  • lactic acid bacteria can be blended alone or in combination of two or more, and the blending amount is preferably 0.0001 to 2.0% by weight, more preferably 0.001 to 1.0% by weight, based on the total composition.
  • the viable number of lactic acid bacteria to be blended is preferably about 10 3 to 10 11 cfu / g, more preferably about 1.0 ⁇ 10 3 to 9.0 ⁇ 10 7 cfu / g. preferable.
  • the amount of 1,3-butylene glycol blended in the oral composition according to the present invention is not particularly limited as long as the effects of the present invention are not impaired, but it is 10 to 80% by weight based on the whole composition. It is preferably 15 to 70% by weight, more preferably 25 to 65% by weight.
  • polyhydric alcohols to be blended in the oral composition other than 1,3-butylene glycol but 1,3-butylene glycol is optimal for stably blending lactic acid bacteria. It is essential for the composition for oral cavity of the present invention.
  • the amount of hydroxyethyl cellulose blended in the oral composition according to the present invention is not particularly limited as long as the effects of the present invention are not impaired, but is preferably 0.01 to 5.0% by weight, based on the total composition, 0.1% More preferred is 2.0% by weight.
  • the hydroxyethyl cellulose preferably has a molecular weight of 90000 to 1000000 (low molecular weight) and a polymerization degree of 300 to 2600, more preferably a molecular weight of 90000 to 500000 and a polymerization degree of 300 to 2000. preferable.
  • any one or two kinds of wetting agents selected from the group consisting of propylene glycol and polyethylene glycol can be further blended, and although not particularly limited, propylene glycol is blended. Is more preferable.
  • the amount of these wetting agents is not particularly limited as long as the effects of the present invention are not impaired, but the total amount of 1,3-butylene glycol and propylene glycol and / or polyethylene glycol is based on the whole composition. 35% by weight or more is preferable, and 45% by weight or more is more preferable.
  • 1,3-butylene glycol / propylene glycol (weight ratio) is preferably 1 or more, more preferably 1 to 6.
  • the composition for oral cavity according to the present invention contains 1,3-butylene glycol and hydroxyethyl cellulose, and even when the water content is low, the bitterness and taste are suppressed.
  • 3-Butylene glycol, propylene glycol and / or polyethylene glycol are blended in the above blending amount to further improve the taste.
  • the total amount of 1,3-butylene glycol and propylene glycol and / or polyethylene glycol is preferably 35 to 80% by weight, more preferably 45 to 70% by weight, based on the entire composition.
  • 1,3-butylene glycol / propylene glycol (weight ratio) in the range of 1 or more, preferably 1 to 10, and more preferably 1 to 6, the taste is further greatly improved. .
  • glycerin may be blended as long as the effects of the present invention are not impaired. Since glycerin has almost no toxicity and exhibits a sweet taste, it is a substance that is preferably blended in the oral composition for improving the taste. However, since it is also a highly viscous substance, care should be taken because the spinnability increases if the amount of glycerin is too large, and the stability of lactic acid bacteria deteriorates if added in large amounts.
  • the oral composition according to the present invention has a taste improved by blending a specific amount of 1,3-butylene glycol, hydroxyethyl cellulose, preferably propylene glycol and / or polyethylene glycol. Accordingly, since glycerin is not necessarily added for improving the taste, the amount of glycerin in the oral composition according to the present invention is only an amount required for further taste improvement. preferable. Specifically, it is preferably 3% by weight or less, more preferably 1% by weight or less, and further preferably 0.5% by weight or less, based on the entire composition. Furthermore, it is preferably 10% by weight or less, more preferably 5% by weight or less, still more preferably 1% by weight or less based on the whole wetting agent.
  • the oral composition according to the present invention may contain a sugar alcohol.
  • Sugar alcohols are blended in general oral compositions as sweeteners and wetting agents, and examples include lactitol, sorbitol, xylitol, erythritol, maltitol, mannitol, and palatinit. Of these, sorbitol and paratinite are particularly preferable.
  • sugar alcohol can be used 1 type or in combination of 2 or more types.
  • the blending amount of the sugar alcohol is not particularly limited as long as the effects of the present invention are not impaired, but is preferably 0.5 to 5% by weight based on the entire composition.
  • a surfactant may also be added to the oral composition according to the present invention.
  • Surfactants are generally blended into oral compositions in order to enhance foamability and cleanability.
  • lactic acid bacteria are blended in the composition for oral cavity of the present invention, blending a large amount of a surfactant having a strong surfactant action is not desirable because it adversely affects its survival and deteriorates stability. Accordingly, amino acid surfactants, amide betaines, alkyl glycosides and the like are particularly suitable.
  • amino acid surfactants include acyl glutamates such as sodium lauroyl glutamate and sodium palmitoyl glutamate, acyl sarcosine salts such as sodium lauroyl sarcosine, acylmethyl taurate, N-lauryl diaminoethyl glycine, and other amino acid surfactants. It can.
  • amide betaines include coconut oil fatty acid amidopropyldimethylaminoacetic acid betaine (cocoamidopropyl betaine), palm kernel oil fatty acid amidopropyldimethylaminoacetic acid betaine, lauric acid amidopropyldimethylaminoacetic acid betaine, and the like.
  • coconut oil fatty acid amidopropyldimethylaminoacetic acid betaine (cocoamidopropyl betaine) is more preferred.
  • alkyl glycoside examples include alkyl glucosides having an alkyl chain length of 8 to 16 carbon atoms.
  • surfactant can be used 1 type or in combination of 2 or more types.
  • the oral composition according to the present invention is not particularly limited, but can be made into usual dosage forms such as a toothpaste, gel, ointment, pasta, gum and the like according to a conventional method.
  • a toothpaste and a gel are preferable, and a toothpaste is most preferable.
  • compositions for oral cavity are not particularly limited as long as the effects of the present invention are not impaired, and those usually used for this type of composition can be blended.
  • abrasives, wetting agents, fragrances, activators, sweeteners, preservatives, colorants, pH adjusters, stabilizers, flavoring agents, astringents, thickeners, other medicinal properties An agent or the like is appropriately blended.
  • wetting agents, fragrances, active agents, sweeteners, preservatives, colorants, pH adjusters, stabilizers, flavoring agents, astringents, thickeners, other medicinal agents Etc. are appropriately blended.
  • dicalcium phosphate dihydrate and anhydrous, calcium phosphate, tricalcium phosphate, calcium carbonate, calcium pyrophosphate, aluminum hydroxide, alumina, anhydrous silicic acid, silica gel, aluminum silicate, insoluble sodium metaphosphate Tertiary magnesium phosphate, magnesium carbonate, calcium sulfate, polymethyl methacrylate, bentonite, zirconium silicate, hydroxyapatite, synthetic resin, and the like can be used.
  • These abrasives may be used alone or in combination of two or more.
  • the usual blending amount of the abrasive is 5 to 70% by weight, and there is no exception even when the oral composition according to the present invention is used as a toothpaste, but preferably 10 to 60% by weight is blended, and 20 to It is more preferable to blend 50% by weight.
  • sodium alkyl sulfates such as sodium lauryl sulfate and sodium myristyl sulfate
  • sugar fatty acid esters such as sucrose fatty acid ester, maltose fatty acid ester and lactose fatty acid ester
  • polyoxyethylene alkyl ethers such as sucrose fatty acid ester, maltose fatty acid ester and lactose fatty acid ester
  • polyoxyethylene alkyl ethers such as sucrose fatty acid ester, maltose fatty acid ester and lactose fatty acid ester
  • polyoxyethylene alkyl ethers such as sucrose fatty acid ester, maltose fatty acid ester and lactose fatty acid ester
  • polyoxyethylene alkyl ethers such as sucrose fatty acid ester, maltose fatty acid ester and lactose fatty acid ester
  • polyoxyethylene alkyl ethers such as sucrose fatty acid ester, maltose
  • blend if it is a grade which does not impair an effect.
  • surfactants can be blended singly or in combination of two or more, and the blending amount is preferably 0.01 to 3.0% by weight, more preferably 0.1 to 3.0% by weight.
  • ethanol glycerin, ethylene glycol, polypropylene glycol, hexylene glycol, or the like can be further used alone or in combination of two or more as long as the effects of the present invention are not impaired.
  • fragrances As fragrances, menthol, anethole, carvone, eugenol, limonene, peppermint oil, spearmint oil, wintergreen, methyl salicylate, cionel, thymol, clove oil, eucalyptus oil, rosemary oil, sage oil, lemon oil, orange oil, ocimen Examples include oil, citronellol, methyl eugenol and the like.
  • flavors can be mix
  • the usual blending amount of the fragrance is 0.05 to 5% by weight.
  • Sweeteners include saccharin sodium, acesulfame potassium, stevioside, neohesperidyl dihydrochalcone, glycyrrhizin, perilartine, thaumatin, asparatylphenylalanyl methyl ester, ⁇ -methoxycinnamic aldehyde, xylit, sucralose, palatinose, steviafin, etc. Can be blended. These sweeteners can be blended alone or in combination of two or more. The usual amount of sweetener is 0.005 to 5% by weight, preferably 0.01 to 0.8% by weight.
  • preservative examples include parabens such as methyl paraben, ethyl paraben, propyl paraben, and butyl paraben, sodium benzoate, phenoxyethanol, and alkyldiaminoethylglycine hydrochloride.
  • colorant examples include legal pigments such as Blue No. 1, Yellow No. 4, Red No. 202, and Green No. 3, mineral pigments such as ultramarine blue, enhanced ultramarine blue, and bitumen, and titanium oxide.
  • Examples of the pH adjuster include citric acid, phosphoric acid, malic acid, pyrophosphoric acid, lactic acid, tartaric acid, glycerophosphoric acid, acetic acid, nitric acid, or a chemically possible salt thereof, sodium hydroxide, and the like.
  • the composition can be blended alone or in combination of two or more so that the pH of the composition is in the range of 5-7.
  • the usual amount of the pH adjuster is 0.01 to 2% by weight.
  • Stabilizers include sodium edetate, sodium thiosulfate, sodium sulfite, sodium chloride, calcium lactate, lanolin, triacetin, castor oil, magnesium sulfate and the like.
  • corrigent examples include tea extract, tea dry distillation liquid, propolis extract, and sodium glutamate.
  • astringents examples include baking soda and aluminum lactate.
  • thickening agents cellulose derivatives such as hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxymethylethylcellulose, xanthan gum, locust bin gum, carrageenan, tragacanth gum, gums such as karaya gum, gum arabic, gellan gum, polyvinyl alcohol, sodium polyacrylate, carboxy
  • synthetic binders such as vinyl polymer and polyvinylpyrrolidone
  • inorganic binders such as thickening silica, aluminum silica gel, and bee gum, sodium alginate, pectin, agar, gelatin, soybean polysaccharide, sodium chondroitin sulfate, sodium hyaluronate, etc. It is also possible to do.
  • These thickeners can be blended alone or in combination of two or more. The normal blending amount of the thickener is 0.01 to 20% by weight.
  • Other medicinal agents include: fluorine compounds such as sodium fluoride, sodium monofluorophosphate, stannous fluoride; enzymes such as dextranase, mutanase, amylase, protease, lytic enzyme (Litech Enzyme); tranexamic acid, ⁇ -aminocaproic acid, aluminum chlorohydroxy allantoin, allantoin, dihydrocholesterol, glycyrrhizic acid, glycyrrhetinic acid, bisabolol, isopropylmethylphenol, glycerophosphoric acid, chlorophyll, copper gluconate, sodium chloride, water-soluble inorganic phosphate compound, chlorhexidine salts, triclosan , Cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride; vitamins such as acetic acid-dl- ⁇ -tocopherol, pyridoxine acetate, ascorbic acid or salts
  • alcohols silicon, apatite, white petrolatum, paraffin, liquid paraffin, microcrystalline wax, squalane and the like can be added.
  • the oral composition according to the present invention is preferably an oral composition having a low water content. If the water content is high, the lactic acid bacteria may be killed in a short period of time, and in this case, it is not possible to maintain the effect throughout the general consumption period of the oral composition. In addition, oral compositions with a low water content often cannot have shape retention even when a thickener is blended, and furthermore, there are many cases where the taste such as bitterness and gummy taste is difficult. However, the composition for oral cavity according to the present invention has at least a water content, good shape retention, and improved bitterness and taste.
  • the oral composition having a low water content preferably has a water content of 0 to 10% by weight, more preferably 0 to 8% by weight, based on the whole oral composition. The water content can be measured by a volumetric titration method described in 2.48 moisture measurement method (Karl Fischer method) of the 15th revision Japanese Pharmacopoeia.
  • each composition (each example and each comparative example) was produced according to the composition described in Table 1, Table 2, and Table 3 below.
  • composition produced in each example was evaluated for bacterial stability, shape retention, stringiness, taste (bitterness, umami), and burning sensation.
  • Examples 1 to 11 and Comparative Examples 1 to 9 were evaluated for fungus stability, shape retention, stringiness, and taste, and Examples 12 to 14 were evaluated for burning feeling, taste, and fungus stability. did.
  • Each composition prepared for shape retention was filled into a tube and left at 40 ° C. (high temperature) and 5 ° C. (low temperature) for 1 month. Thereafter, all the tubes were squeezed out, and the shape retention was visually evaluated according to the following criteria.
  • the evaluation criteria are as follows. ⁇ : The squeezed shape is retained for 5 minutes or longer. ⁇ : The shape is retained during squeezing, but the shape disappears in less than 5 minutes. ⁇ : There is no shape retention at the time of squeezing.
  • Burning feeling (heat feeling) About 0.5 g of each produced composition was taken in a toothbrush and used in a normal manner, and sensory evaluation was carried out on five professional panelists based on the following evaluation criteria.
  • the evaluation criteria are as follows. ⁇ : Feeling no burning at all ⁇ : Feeling little burning ⁇ : Feeling a little burning sensation: Feeling a little burning
  • the table below shows the blending amount at the time of preparing the composition and the results of the performance evaluation of the composition.
  • surface represents the compounding quantity in weight%.
  • comprehensive evaluation was performed by four-step evaluation of x, (triangle
  • the composition containing 1,3-butylene glycol and hydroxyethyl cellulose has good stability of lactic acid bacteria, shape retention, and good spinnability. It was confirmed that the taste was improved.
  • Examples 4 and 5 are excellent in all evaluation items, and the total amount of 1,3-butylene glycol, propylene glycol and / or polyethylene glycol is 45 to 70% by weight, and It was also found that the taste was further improved by blending 1,3-butylene glycol / propylene glycol (weight ratio) in the range of 1-6.
  • Examples 12 to 14 are examples in which sorbitol, palatinit, and glycerin were used to further improve the taste of the oral composition of the present application.
  • Table 3 the taste and the stability of the bacteria are not good or bad, but for the burning sensation, the composition using sugar alcohol sorbitol and paratinite is more than the composition using glycerin, Greatly improved. From this, it was confirmed that among the substances used to improve the taste, sugar alcohol can greatly improve the burning sensation of the oral composition according to the present application.

Abstract

Disclosed is a composition for oral application, into which a lactic acid bacterium can be blended alive stably, which has largely improved bitter taste and harsh taste even when the composition has a low water content, and which has shape-retaining properties and proper stringiness. Specifically disclosed is a composition for oral application, which is characterized by comprising a lactic acid bacterium, 1,3-butylene glycol and hydroxyethylcellulose.

Description

口腔用組成物Oral composition
 本発明は口腔用組成物に関し、詳細には、乳酸菌を安定に含有し、保形性、味に優れた口腔用組成物に関する。 The present invention relates to an oral composition, and in particular, relates to an oral composition that stably contains lactic acid bacteria and has excellent shape retention and taste.
 口腔用組成物には、機能・効能の付与を目的として、製剤に種々の有効成分を配合することがあり、有効成分としてはフッ化物、殺菌成分、抗炎症成分、歯石の沈着防止成分、止血剤等が挙げられる。また近年は、乳酸菌、植物抽出物、生薬等が副作用の少ない人体に優しいナチュラルな殺菌・静菌成分として、口腔用組成物に配合されるようになってきている。なかでも乳酸菌は、う蝕原因菌や歯周病原因菌の存在する口腔内に作用させることで、菌同士の生存競争によりう蝕原因菌や歯周病原因菌を静菌すると考えられており、副作用等の悪影響が少ない人体に優しい有効成分として注目されている。 The oral composition may contain various active ingredients in the preparation for the purpose of imparting function and efficacy. The active ingredients include fluoride, bactericidal ingredients, anti-inflammatory ingredients, anticalculus ingredients, hemostasis Agents and the like. In recent years, lactic acid bacteria, plant extracts, herbal medicines and the like have been incorporated into oral compositions as natural bactericidal and bacteriostatic components that are gentle on the human body and have few side effects. In particular, lactic acid bacteria are considered to act as bacteriostatic agents for periodontal disease and periodontal disease by acting in the oral cavity where caries-causing bacteria and periodontal disease-causing bacteria are present. It is attracting attention as an active ingredient gentle to the human body with less adverse effects such as side effects.
 しかし、乳酸菌は、水分や化学物質の影響を受けやすく、生きたまま乳酸菌を長期間安定に配合することは困難である。このような観点から、水分含有量を少なくすることが考えられるが、このような口腔用組成物は水以外の有機溶剤を多量に含有するため、乳酸菌の安定性に加え、苦味、えぐ味など味に難がある場合が多い。 However, lactic acid bacteria are easily affected by moisture and chemical substances, and it is difficult to stably mix lactic acid bacteria for a long period of time. From such a point of view, it is conceivable to reduce the water content, but since such oral compositions contain a large amount of organic solvents other than water, in addition to the stability of lactic acid bacteria, bitterness, gummy taste, etc. There are many cases where the taste is difficult.
 また、一般的な口腔用組成物には、例えばカルボキシメチルセルロースナトリウム、カラギーナン、或いはキサンタンガムといった増粘剤が主体として配合されており、これらの成分が水に溶けることで粘性を発現し、粉体成分と液体成分を結合させ、保形性及び適度な粘性を与えている。しかし、水分含有量が少ない口腔用組成物においては、増粘剤を配合してもその粘度が増加しないために保形性を得ることが難しく、経時的に粉体成分と液体成分の分離が起きてしまう。 Further, in general oral compositions, for example, a thickener such as sodium carboxymethylcellulose, carrageenan, or xanthan gum is mainly blended, and these components dissolve in water to develop viscosity, and powder components And liquid components are combined to give shape retention and moderate viscosity. However, in oral compositions with low water content, it is difficult to obtain shape retention because the viscosity does not increase even if a thickener is added, and the powder component and liquid component can be separated over time. I get up.
 このように水分含有量の少ない口腔用組成物においては、乳酸菌を安定配合することは困難である上、味及び保形性等の問題も存在するのが現状である。こういった問題点を解決するべく、これまでにも様々な研究が行われており、種々の特許文献が開示されている。 In such an oral composition having a low water content, it is difficult to stably mix lactic acid bacteria, and there are also problems such as taste and shape retention. In order to solve these problems, various studies have been conducted so far and various patent documents have been disclosed.
 例えば、特許文献1(特開2002-302429号公報)には、重曹を非水系口腔用組成物用基剤に含有させることで、使用時に苦みやえぐみを緩和した口腔用組成物が開示されている。また、特許文献2(特開2002-255772号公報)及び特許文献3(特開2007-23056号公報)には、特定の成分を配合することで、保形性があってかつ安定性の高い口腔用組成物を得られることを開示されている。しかし、これらに開示された口腔用組成物は、味や保形性において十分ではない点があり、また乳酸菌を配合した時の安定性については全く記載されていない。さらに口腔用組成物の使用及び製造段階において重要である曳糸性についても明らかにされていない。 For example, Patent Document 1 (Japanese Patent Application Laid-Open No. 2002-302429) discloses an oral composition in which bitterness and itchiness are alleviated by using sodium bicarbonate in a non-aqueous oral composition base. Yes. In addition, Patent Document 2 (Japanese Patent Laid-Open No. 2002-255572) and Patent Document 3 (Japanese Patent Laid-Open No. 2007-23056) have a shape retention property and high stability by blending specific components. It is disclosed that an oral composition can be obtained. However, the oral compositions disclosed in these publications are not sufficient in taste and shape retention, and are not described at all when they contain lactic acid bacteria. Furthermore, the spinnability, which is important in the use and production stage of the oral composition, has not been clarified.
 また、特許文献4(特開2005-298346号公報)には乳酸菌および/またはビフィズス菌とハイドロキシアパタイトを配合した非水系口腔用組成物が、特許文献5(特開2007-131601号公報)には特定の乳酸菌(S.faecalis)を配合した非水系口腔用組成物が開示されているが、いずれも組成物の味については明らかにされておらず、また乳酸菌の安定性についても不明である。 Patent Document 4 (Japanese Patent Laid-Open No. 2005-298346) discloses a non-aqueous oral composition containing lactic acid bacteria and / or bifidobacteria and hydroxyapatite, and Patent Document 5 (Japanese Patent Laid-Open No. 2007-131601). Non-aqueous oral compositions containing a specific lactic acid bacterium (S.faecalis) have been disclosed, but none of the composition has been clarified about the taste, and the stability of the lactic acid bacterium is unknown.
 そこで、本発明者らは、上記の問題を解決すべく鋭意研究を行った結果、1,3-ブチレングリコール及びヒドロキシエチルセルロースを含有する口腔用組成物であれば、乳酸菌を生菌のまま安定に配合することが可能であり、かつ、水含有量が少なくとも苦み及びえぐ味が大幅に改善されるうえに、保形性および好適な曳糸性をも有することを見出し、さらに改良を重ねて本発明を完成させるに至った。
特開2002-302429号公報 特開2002-255772号公報 特開2007-023056号公報 特開2005-298346号公報 特開2007-131601号公報
Thus, as a result of intensive studies to solve the above problems, the present inventors have found that a composition for oral cavity containing 1,3-butylene glycol and hydroxyethyl cellulose can stably stabilize lactic acid bacteria as living bacteria. It has been found that it can be blended and the water content at least improves bitterness and savory taste, and also has shape retention and suitable spinnability. The invention has been completed.
JP 2002-302429 A Japanese Patent Laid-Open No. 2002-255772 JP 2007-023056 A JP 2005-298346 A Japanese Patent Laid-Open No. 2007-131601
 本発明は、乳酸菌を生菌のまま安定に配合することが可能であり、かつ、水含有量が少なくとも苦み及びえぐ味が大幅に改善されるうえに、保形性および好適な曳糸性をも有する口腔用組成物を提供することを目的とする。 The present invention is capable of stably blending lactic acid bacteria in a live state, and at the same time, the water content is at least significantly improved in bitterness and savory taste, and has shape retention and suitable stringiness. An object of the present invention is to provide a composition for an oral cavity that also has a composition.
 本発明者らは、上記問題を解決すべく鋭意検討を重ねた結果、1,3-ブチレングリコール及びヒドロキシエチルセルロースを含有する口腔用組成物であれば、乳酸菌を生菌のまま安定に配合することが可能であり、かつ、水含有量が少なくとも苦み及びえぐ味が大幅に改善されるうえに、保形性および好適な曳糸性をも有することを見出した。 As a result of intensive studies to solve the above problems, the inventors of the present invention can stably mix lactic acid bacteria as viable bacteria if it is an oral composition containing 1,3-butylene glycol and hydroxyethyl cellulose. It has been found that the water content is at least significantly improved in bitterness and taste, and also has shape retention and suitable spinnability.
 本発明は、特に以下の項1~6の口腔用組成物を提供するものである。
項1.乳酸菌、1,3-ブチレングリコール及びヒドロキシエチルセルロースを含有する口腔用組成物。
項2.さらに、プロピレングリコール及びポリエチレングリコールからなる群から選ばれるいずれか1種又は2種の湿潤剤を含有する、請求項1に記載の口腔用組成物。
項3.1,3-ブチレングリコールと、プロピレングリコール及び/又はポリエチレングリコールの合計量が35重量%以上である、請求項1又は2に記載の口腔用組成物。
項4.乳酸菌、1,3-ブチレングリコール、プロピレングリコール及びヒドロキシエチルセルロースを含有し、1,3-ブチレングリコール/プロピレングリコール(重量比)が1以上である、請求項1~3のいずれか1項に記載の口腔用組成物。
項5.さらに、糖アルコールを含有する、請求項1~4のいずれか1項に記載の口腔用組成物。
項6.さらに、アミノ酸系界面活性剤、アミドベタイン及びアルキルグリコシドからなる群より選択される少なくとも1種の界面活性剤を含有する、請求項1~5のいずれか1項に記載の口腔用組成物。
The present invention particularly provides the oral composition according to items 1 to 6 below.
Item 1. An oral composition containing lactic acid bacteria, 1,3-butylene glycol and hydroxyethyl cellulose.
Item 2. Furthermore, the composition for oral cavity of Claim 1 containing any 1 type or 2 types of wetting agents chosen from the group which consists of propylene glycol and polyethyleneglycol.
Item 3. The oral composition according to claim 1 or 2, wherein the total amount of 1,3-butylene glycol and propylene glycol and / or polyethylene glycol is 35% by weight or more.
Item 4. The lactic acid bacterium, 1,3-butylene glycol, propylene glycol and hydroxyethyl cellulose are contained, and 1,3-butylene glycol / propylene glycol (weight ratio) is 1 or more, according to any one of claims 1 to 3. Oral composition.
Item 5. The oral composition according to any one of claims 1 to 4, further comprising a sugar alcohol.
Item 6. The oral composition according to any one of claims 1 to 5, further comprising at least one surfactant selected from the group consisting of amino acid surfactants, amide betaines, and alkyl glycosides.
 本発明によれば、乳酸菌を生菌のまま安定に配合することが可能であり、かつ、水含有量が少なくとも苦み及びえぐ味が大幅に改善されるうえに、保形性および好適な曳糸性をも有する口腔用組成物を提供することができる。 According to the present invention, it is possible to stably mix lactic acid bacteria as living bacteria, and at the same time, the water content is at least greatly improved in bitterness and gummy taste, and the shape retention and suitable silk thread The composition for oral cavity which also has property can be provided.
 本願に係る口腔用組成物によれば、乳酸菌を安定配合することにより、口腔内環境(特に口腔内フローラの菌のバランス)を整え、例えばう蝕原因菌や歯周病原因菌といった人体に悪影響を及ぼす菌を静菌することができる。このように、乳酸菌は副作用の少ない人体に優しいナチュラルな静菌成分であり、安定配合することで、昨今の人々の健康志向にも応えることができる。 According to the composition for oral cavity according to the present application, by stably blending lactic acid bacteria, the oral environment (especially the balance of bacteria in the oral flora) is adjusted and adversely affects the human body such as caries-causing bacteria and periodontal disease-causing bacteria. Can be bacteriostatic. In this way, lactic acid bacteria are natural bacteriostatic components that are gentle on the human body with few side effects, and can stably meet the health-consciousness of recent people by blending stably.
 また、本願に係る口腔用組成物は保形性を有するため、例えば使用時に使用分量だけ取り出した時に形が崩れてひとまとまりとして使用するのに不便であるとか、あるいは歯ブラシにのせた時にブラシ中に沈み込んでしまうといった様な問題は起こらない。また、口腔用組成物は口腔内に入れて使用するものであり、味の良し悪しも消費者にとって重要なポイントとなるが、本願に係る口腔用組成物であれば、苦み及びえぐ味のために不快感を味わうこともない。さらに、製造時及び使用時において曳糸性に起因する不都合が生じることも無い。 In addition, since the composition for oral cavity according to the present application has shape retentivity, it is inconvenient to use as a unit when the used amount is taken out at the time of use, or when placed on a toothbrush. There will be no problems such as sinking in. In addition, the oral composition is used in the oral cavity, and whether the taste is good or bad is an important point for consumers. There is no discomfort. Further, there is no inconvenience due to the stringiness during manufacture and use.
 以下、本発明につき更に詳細に説明する。 Hereinafter, the present invention will be described in more detail.
 本発明に係る口腔用組成物は、乳酸菌、1,3-ブチレングリコール及びヒドロキシエチルセルロースを含有するものである。 The oral composition according to the present invention contains lactic acid bacteria, 1,3-butylene glycol and hydroxyethyl cellulose.
 本発明に係る口腔用組成物に配合される乳酸菌としては、乳酸菌による本発明の効果を達成できるものであれば特に限定されるものではないが、S.faecium、L.reuteri、L.gasseri、L.salivalius、L.mesenteroides、L.brevis、L.acidophilus、L.brugaricus、L.plantarum及び S.faecalisであることが好ましく、なかでもS.faecium、L.gasseri、L.mesenteroides、L.brevis、L.acidophilus及びS.faecalisが好ましい。これらの乳酸菌は1種又は2種以上を組み合わせて配合することができ、その配合量は組成物全体に対して0.0001~2.0重量%が好ましく、0.001~1.0重量%がより好ましい。効果を達成するためには、配合される乳酸菌の生菌数は約10~1011cfu/gであることが好ましく、約1.0×10~9.0×10cfu/gであることがより好ましい。 The lactic acid bacterium blended in the oral composition according to the present invention is not particularly limited as long as the effect of the present invention by the lactic acid bacterium can be achieved, but S.faecium, L.reuteri, L.gasseri, L. salivalius, L. mesenteroides, L. brevis, L. acidophilus, L. brugaricus, L. plantarum and S. faecalis are preferred, and among them, S. faecium, L. gasseri, L. mesenteroides, L. brevis L. acidophilus and S. faecalis are preferred. These lactic acid bacteria can be blended alone or in combination of two or more, and the blending amount is preferably 0.0001 to 2.0% by weight, more preferably 0.001 to 1.0% by weight, based on the total composition. In order to achieve the effect, the viable number of lactic acid bacteria to be blended is preferably about 10 3 to 10 11 cfu / g, more preferably about 1.0 × 10 3 to 9.0 × 10 7 cfu / g. preferable.
 本発明に係る口腔用組成物に配合される1,3-ブチレングリコール量は、本発明の効果を損なわない限り特に限定されるものではないが、組成物全体に対して、10~80重量%が好ましく、15~70重量%がより好ましく、25~65重量%がさらに好ましい。なお、口腔用組成物に配合される多価アルコールは、1,3-ブチレングリコール以外にも多々存在するが、乳酸菌を安定に配合するためには、1,3-ブチレングリコールが最適であり、本発明の口腔用組成物には必須である。 The amount of 1,3-butylene glycol blended in the oral composition according to the present invention is not particularly limited as long as the effects of the present invention are not impaired, but it is 10 to 80% by weight based on the whole composition. It is preferably 15 to 70% by weight, more preferably 25 to 65% by weight. There are many polyhydric alcohols to be blended in the oral composition other than 1,3-butylene glycol, but 1,3-butylene glycol is optimal for stably blending lactic acid bacteria. It is essential for the composition for oral cavity of the present invention.
 本発明に係る口腔用組成物に配合されるヒドロキシエチルセルロース量は、本発明の効果を損なわない限り特に限定されるものではないが、組成物全体に対して、0.01~5.0重量%が好ましく、0.1~2.0重量%がより好ましい。また、当該ヒドロキシエチルセルロースは、分子量90000~1000000(低分子量)、重合度300~2600の範囲のものであることが好ましく、分子量90000~500000、重合度300~2000の範囲のものであることがより好ましい。 The amount of hydroxyethyl cellulose blended in the oral composition according to the present invention is not particularly limited as long as the effects of the present invention are not impaired, but is preferably 0.01 to 5.0% by weight, based on the total composition, 0.1% More preferred is 2.0% by weight. The hydroxyethyl cellulose preferably has a molecular weight of 90000 to 1000000 (low molecular weight) and a polymerization degree of 300 to 2600, more preferably a molecular weight of 90000 to 500000 and a polymerization degree of 300 to 2000. preferable.
 本発明に係る口腔用組成物には、さらにプロピレングリコール及びポリエチレングリコールからなる群から選ばれるいずれか1種又は2種の湿潤剤を配合でき、特に限定するものではないが、プロピレングリコールを配合するのがより好ましい。これら湿潤剤の配合量は、本発明の効果を損なわない限り特に限定されるものではないが、1,3-ブチレングリコールと、プロピレングリコール及び/又はポリエチレングリコールの合計量が組成物全体に対して、35重量%以上のものが好ましく、45重量%以上がさらに好ましい。 In the composition for oral cavity according to the present invention, any one or two kinds of wetting agents selected from the group consisting of propylene glycol and polyethylene glycol can be further blended, and although not particularly limited, propylene glycol is blended. Is more preferable. The amount of these wetting agents is not particularly limited as long as the effects of the present invention are not impaired, but the total amount of 1,3-butylene glycol and propylene glycol and / or polyethylene glycol is based on the whole composition. 35% by weight or more is preferable, and 45% by weight or more is more preferable.
 またさらに、プロピレングリコールが配合される場合は、1,3-ブチレングリコール/プロピレングリコール(重量比)が1以上であることが好ましく、1~6であることがより好ましい。 Furthermore, when propylene glycol is blended, 1,3-butylene glycol / propylene glycol (weight ratio) is preferably 1 or more, more preferably 1 to 6.
 本発明に係る口腔用組成物は、1,3-ブチレングリコール及びヒドロキシエチルセルロースを配合したものであり、水分含有量が少ないものであっても、苦み及びえぐ味が抑えられるものであるが、1,3-ブチレングリコール、プロピレングリコール及び/又はポリエチレングリコールが上記の配合量で配合されることで、さらに味が改善される。特に、1,3-ブチレングリコールと、プロピレングリコール及び/又はポリエチレングリコールの合計量が組成物全体に対して、35~80重量%であることが好ましく、45~70重量%であることがより好ましい。さらに、1,3-ブチレングリコール/プロピレングリコール(重量比)が1以上、好ましくは1~10、さらに好ましくは1~6の範囲内になるよう配合することで、さらに大幅に味が改善される。 The composition for oral cavity according to the present invention contains 1,3-butylene glycol and hydroxyethyl cellulose, and even when the water content is low, the bitterness and taste are suppressed. , 3-Butylene glycol, propylene glycol and / or polyethylene glycol are blended in the above blending amount to further improve the taste. In particular, the total amount of 1,3-butylene glycol and propylene glycol and / or polyethylene glycol is preferably 35 to 80% by weight, more preferably 45 to 70% by weight, based on the entire composition. . Furthermore, by adding 1,3-butylene glycol / propylene glycol (weight ratio) in the range of 1 or more, preferably 1 to 10, and more preferably 1 to 6, the taste is further greatly improved. .
 本発明に係る口腔用組成物には、本願発明の効果を損なわない範囲であればグリセリンを配合してもよい。グリセリンは毒性がほとんど無く甘味を呈するため、味の改善のために口腔用組成物に好んで配合される物質である。但し、粘性の高い物質でもあるため、グリセリン配合量が多すぎると曳糸性が大きくなり、また、多量に配合すると乳酸菌の安定性も悪くなってしまうため注意を要する。 In the composition for oral cavity according to the present invention, glycerin may be blended as long as the effects of the present invention are not impaired. Since glycerin has almost no toxicity and exhibits a sweet taste, it is a substance that is preferably blended in the oral composition for improving the taste. However, since it is also a highly viscous substance, care should be taken because the spinnability increases if the amount of glycerin is too large, and the stability of lactic acid bacteria deteriorates if added in large amounts.
 上記のとおり、本発明に係る口腔用組成物は、1,3-ブチレングリコール、ヒドロキシエチルセルロース、好ましくはさらにプロピレングリコール及び/又はポリエチレングリコールを特定量配合することで味が改善されたものである。従って、味の改善のために必ずしもグリセリンを配合しなければならないものではないため、本発明に係る口腔用組成物におけるグリセリン配合量は、さらなる味の改善に必要とされる量のみであることが好ましい。具体的には、組成物全体に対して、3重量%以下が好ましく、1重量%以下がより好ましく、0.5重量%以下がさらに好ましい。またさらに、湿潤剤全体に対して、10重量%以下が好ましく、5重量%以下がより好ましく、1重量%以下がさらに好ましい。 As described above, the oral composition according to the present invention has a taste improved by blending a specific amount of 1,3-butylene glycol, hydroxyethyl cellulose, preferably propylene glycol and / or polyethylene glycol. Accordingly, since glycerin is not necessarily added for improving the taste, the amount of glycerin in the oral composition according to the present invention is only an amount required for further taste improvement. preferable. Specifically, it is preferably 3% by weight or less, more preferably 1% by weight or less, and further preferably 0.5% by weight or less, based on the entire composition. Furthermore, it is preferably 10% by weight or less, more preferably 5% by weight or less, still more preferably 1% by weight or less based on the whole wetting agent.
 本発明に係る口腔用組成物には、糖アルコールを配合してもよい。糖アルコールは甘味剤や湿潤剤として一般的な口腔用組成物に配合されるものであり、ラクチトール、ソルビトール、キシリトール、エリスリトール、マルチトール、マンニトール、パラチニットなどが例示できる。なかでもソルビト-ル、パラチニットが特に好ましい。なお、糖アルコールは、1種又は2種以上を組み合わせて用いることができる。糖アルコールの配合量は、本発明の効果を損なわない限り特に限定されるものではないが、組成物全体に対して、0.5~5重量%が好ましい。糖アルコールを配合することにより、冷涼感及び甘味が付加されて、水分量の少ない口腔用組成物の灼熱(温熱)感や苦みを和らげ、使用感を大きく改善することができる。 The oral composition according to the present invention may contain a sugar alcohol. Sugar alcohols are blended in general oral compositions as sweeteners and wetting agents, and examples include lactitol, sorbitol, xylitol, erythritol, maltitol, mannitol, and palatinit. Of these, sorbitol and paratinite are particularly preferable. In addition, sugar alcohol can be used 1 type or in combination of 2 or more types. The blending amount of the sugar alcohol is not particularly limited as long as the effects of the present invention are not impaired, but is preferably 0.5 to 5% by weight based on the entire composition. By blending the sugar alcohol, a cooling sensation and sweetness are added to relieve the burning (hot) feeling and bitterness of the oral composition with a low water content, and the feeling of use can be greatly improved.
 本発明に係る口腔用組成物にはまた、界面活性剤が配合され得る。界面活性剤は、発泡性及び洗浄性を高めるために、口腔用組成物に一般に配合されるものである。但し、本発明の口腔用組成物には乳酸菌を配合するため、界面活性作用の強い界面活性剤を多量に配合するとその生存に悪影響を及ぼし、安定性が悪くなるので望ましくない。従って、特にアミノ酸系界面活性剤、アミドベタイン、アルキルグリコシド等が好適である。アミノ酸系界面活性剤としては、ラウロイルグルタミン酸ナトリウム、パルミトイルグルタミン酸ナトリウム等のアシルグルタミン酸塩、ラウロイルサルコシンナトリウム等のアシルサルコシン塩、アシルメチルタウリン塩、N-ラウリルジアミノエチルグリシン、その他アミノ酸界面活性剤等が例示できる。また、アミドベタインとしては、例えば、ヤシ油脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン(ココアミドプロピルベタイン)、パーム核油脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン、ラウリン酸アミドプロピルジメチルアミノ酢酸ベタイン等が挙げられ、このうち、ヤシ油脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン(ココアミドプロピルベタイン)がより好ましい。アルキルグリコシドとしては、アルキル鎖長が炭素数8~16であるアルキルグルコシドが挙げられる。なお、界面活性剤は、1種又は2種以上を組み合わせて用いることができる。 A surfactant may also be added to the oral composition according to the present invention. Surfactants are generally blended into oral compositions in order to enhance foamability and cleanability. However, since lactic acid bacteria are blended in the composition for oral cavity of the present invention, blending a large amount of a surfactant having a strong surfactant action is not desirable because it adversely affects its survival and deteriorates stability. Accordingly, amino acid surfactants, amide betaines, alkyl glycosides and the like are particularly suitable. Examples of amino acid surfactants include acyl glutamates such as sodium lauroyl glutamate and sodium palmitoyl glutamate, acyl sarcosine salts such as sodium lauroyl sarcosine, acylmethyl taurate, N-lauryl diaminoethyl glycine, and other amino acid surfactants. it can. Examples of amide betaines include coconut oil fatty acid amidopropyldimethylaminoacetic acid betaine (cocoamidopropyl betaine), palm kernel oil fatty acid amidopropyldimethylaminoacetic acid betaine, lauric acid amidopropyldimethylaminoacetic acid betaine, and the like. Of these, coconut oil fatty acid amidopropyldimethylaminoacetic acid betaine (cocoamidopropyl betaine) is more preferred. Examples of the alkyl glycoside include alkyl glucosides having an alkyl chain length of 8 to 16 carbon atoms. In addition, surfactant can be used 1 type or in combination of 2 or more types.
 本発明に係る口腔用組成物は、特に限定するものではないが、常法に従って例えば練歯磨剤、ジェル剤、軟膏状製剤、パスタ剤、ガム剤等の通常の剤形にすることができる。なかでも、練歯磨剤、ジェル剤であることが好ましく、練歯磨剤が最も好ましい。 The oral composition according to the present invention is not particularly limited, but can be made into usual dosage forms such as a toothpaste, gel, ointment, pasta, gum and the like according to a conventional method. Among these, a toothpaste and a gel are preferable, and a toothpaste is most preferable.
 本発明に係る口腔用組成物は、本発明の効果を損なわない限り、他の基剤成分は特に限定するものではなく、通常この種の組成物に用いられるものを配合できる。例えば、練歯磨の場合であれば研磨剤、湿潤剤、香料、活性剤、甘味剤、防腐剤、着色剤、pH調整剤、安定化剤、矯味剤、収れん剤、増粘剤、他の薬効剤等が適宜配合される。また、軟膏状製剤の場合であれば、湿潤剤、香料、活性剤、甘味剤、防腐剤、着色剤、pH調整剤、安定化剤、矯味剤、収れん剤、増粘剤、他の薬効剤等が適宜配合される。 In the composition for oral cavity according to the present invention, other base components are not particularly limited as long as the effects of the present invention are not impaired, and those usually used for this type of composition can be blended. For example, in the case of toothpaste, abrasives, wetting agents, fragrances, activators, sweeteners, preservatives, colorants, pH adjusters, stabilizers, flavoring agents, astringents, thickeners, other medicinal properties An agent or the like is appropriately blended. In the case of ointment-like preparations, wetting agents, fragrances, active agents, sweeteners, preservatives, colorants, pH adjusters, stabilizers, flavoring agents, astringents, thickeners, other medicinal agents Etc. are appropriately blended.
 研磨剤としては、第2リン酸カルシウム・2水和物及び無水和物、リン酸カルシウム、第3リン酸カルシウム、炭酸カルシウム、ピロリン酸カルシウム、水酸化アルミニウム、アルミナ、無水ケイ酸、シリカゲル、ケイ酸アルミニウム、不溶性メタリン酸ナトリウム、第3リン酸マグネシウム、炭酸マグネシウム、硫酸カルシウム、ポリメタクリル酸メチル、ベントナイト、ケイ酸ジルコニウム、ハイドロキシアパタイト、合成樹脂等を用いることができる。これらの研磨剤は単独で用いても、2種以上を併用してもよい。研磨剤の通常配合量は5~70重量%であり、本発明に係る口腔用組成物を練り歯磨き剤として使用する場合も例外ではないが、10~60重量%配合することが好ましく、20~50重量%配合するのがより好ましい。 As abrasives, dicalcium phosphate dihydrate and anhydrous, calcium phosphate, tricalcium phosphate, calcium carbonate, calcium pyrophosphate, aluminum hydroxide, alumina, anhydrous silicic acid, silica gel, aluminum silicate, insoluble sodium metaphosphate Tertiary magnesium phosphate, magnesium carbonate, calcium sulfate, polymethyl methacrylate, bentonite, zirconium silicate, hydroxyapatite, synthetic resin, and the like can be used. These abrasives may be used alone or in combination of two or more. The usual blending amount of the abrasive is 5 to 70% by weight, and there is no exception even when the oral composition according to the present invention is used as a toothpaste, but preferably 10 to 60% by weight is blended, and 20 to It is more preferable to blend 50% by weight.
 界面活性剤としては、前述のように界面活性作用の強い界面活性剤を多量に配合すると乳酸菌の安定性が悪くなるため望ましくなく、アミノ酸系界面活性剤、アミドベタイン、アルキルグリコシド等が好適に用い得るが、ラウリル硫酸ナトリウム、ミリスチル硫酸ナトリウム等のアルキル硫酸ナトリウム、ショ糖脂肪酸エステル、マルトース脂肪酸エステル、ラクトース脂肪酸エステル等の糖脂肪酸エステル、ポリオキシエチレンアルキルエーテル類、脂肪酸アルカノールアミド類、ポリオキシエチレンソルビタンモノラウレート、ポリオキシエチレンソルビタンモノステアレート等のポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ソルビタン脂肪酸エステル、ポリグリセリン脂肪酸エステル、脂肪酸モノグリセライド、N-ラウリルジアミノエチルグリシン、N-ミリスチルジエチルグリシン等のN-アルキルジアミノエチルグリシン、N-アルキル-N-カルボキシメチルアンモニウムベタイン、ラウリルジメチルアミノ酢酸ベタイン等の界面活性剤も、本発明の効果を損なわない程度であれば配合してもよい。なお、これらの界面活性剤は、単独又は2種以上を組み合わせて配合でき、その配合量は、好ましくは0.01~3.0重量%であり、さらに好ましくは0.1~3.0重量%である。 As described above, it is not desirable to add a large amount of a surfactant having a strong surfactant action as described above, since the stability of lactic acid bacteria is deteriorated. Amino acid surfactants, amide betaines, alkylglycosides, etc. are preferably used. Obtained, sodium alkyl sulfates such as sodium lauryl sulfate and sodium myristyl sulfate, sugar fatty acid esters such as sucrose fatty acid ester, maltose fatty acid ester and lactose fatty acid ester, polyoxyethylene alkyl ethers, fatty acid alkanolamides, polyoxyethylene sorbitan Polyoxyethylene sorbitan fatty acid ester such as monolaurate, polyoxyethylene sorbitan monostearate, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid ester, polyglycerin fatty acid ester, fatty acid Surfactants such as N-alkyldiaminoethylglycine such as noglyceride, N-lauryldiaminoethylglycine and N-myristyldiethylglycine, N-alkyl-N-carboxymethylammonium betaine, and lauryldimethylaminoacetic acid betaine are also used in the present invention. You may mix | blend if it is a grade which does not impair an effect. These surfactants can be blended singly or in combination of two or more, and the blending amount is preferably 0.01 to 3.0% by weight, more preferably 0.1 to 3.0% by weight.
 湿潤剤としては、本発明の効果を損なわない程度であれば、さらにエタノール、グリセリン、エチレングリコール、ポリプロピレングリコール、ヘキシレングリコール等を単独または2種以上を組み合わせて配合することができる。 As the wetting agent, ethanol, glycerin, ethylene glycol, polypropylene glycol, hexylene glycol, or the like can be further used alone or in combination of two or more as long as the effects of the present invention are not impaired.
 香料としては、メントール、アネトール、カルボン、オイゲノール、リモネン、ペパーミントオイル、スペアミントオイル、ウインターグリーン、サリチル酸メチル、シオネール、チモール、丁字油、ユーカリ油、ローズマリー油、セージ油、レモン油、オレンジ油、オシメン油、シトロネロール、メチルオイゲノール等が挙げられる。これらの香料は、単独または2種以上を組み合わせて配合することができる。香料の通常配合量は、0.05~5重量%である。 As fragrances, menthol, anethole, carvone, eugenol, limonene, peppermint oil, spearmint oil, wintergreen, methyl salicylate, cionel, thymol, clove oil, eucalyptus oil, rosemary oil, sage oil, lemon oil, orange oil, ocimen Examples include oil, citronellol, methyl eugenol and the like. These fragrance | flavors can be mix | blended individually or in combination of 2 or more types. The usual blending amount of the fragrance is 0.05 to 5% by weight.
 甘味剤としては、サッカリンナトリウム、アセスルファームカリウム、ステビオサイド、ネオヘスペリジルジヒドロカルコン、グリチルリチン、ペリラルチン、タウマチン、アスパラチルフェニルアラニルメチルエステル、α-メトキシシンナミックアルデヒド、キシリット、スクラロース、パラチノース、ステビアフィン等を配合することができる。これらの甘味剤は、単独または2種以上を組み合わせて配合することができる。甘味剤の通常配合量は0.005~5重量%、好ましくは0.01~0.8重量%である。 Sweeteners include saccharin sodium, acesulfame potassium, stevioside, neohesperidyl dihydrochalcone, glycyrrhizin, perilartine, thaumatin, asparatylphenylalanyl methyl ester, α-methoxycinnamic aldehyde, xylit, sucralose, palatinose, steviafin, etc. Can be blended. These sweeteners can be blended alone or in combination of two or more. The usual amount of sweetener is 0.005 to 5% by weight, preferably 0.01 to 0.8% by weight.
 防腐剤としては、メチルパラベン、エチルパラベン、プロピルパラベン、ブチルパラベン等のパラベン類、安息香酸ナトリウム、フェノキシエタノール、塩酸アルキルジアミノエチルグリシン等が挙げられる。 Examples of the preservative include parabens such as methyl paraben, ethyl paraben, propyl paraben, and butyl paraben, sodium benzoate, phenoxyethanol, and alkyldiaminoethylglycine hydrochloride.
 着色剤としては、青色1号、黄色4号、赤色202号、緑3号等の法定色素、群青、強化群青、紺青等の鉱物系色素、酸化チタン等が挙げられる。 Examples of the colorant include legal pigments such as Blue No. 1, Yellow No. 4, Red No. 202, and Green No. 3, mineral pigments such as ultramarine blue, enhanced ultramarine blue, and bitumen, and titanium oxide.
 pH調整剤としては、クエン酸、リン酸、リンゴ酸、ピロリン酸、乳酸、酒石酸、グリセロリン酸、酢酸、硝酸、またはこれらの化学的に可能な塩や水酸化ナトリウム等が挙げられ、これらは、組成物のpHが5~7の範囲となるよう、単独または2種以上を組み合わせて配合することができる。pH調整剤の通常配合量は0.01~2重量%である。 Examples of the pH adjuster include citric acid, phosphoric acid, malic acid, pyrophosphoric acid, lactic acid, tartaric acid, glycerophosphoric acid, acetic acid, nitric acid, or a chemically possible salt thereof, sodium hydroxide, and the like. The composition can be blended alone or in combination of two or more so that the pH of the composition is in the range of 5-7. The usual amount of the pH adjuster is 0.01 to 2% by weight.
 安定化剤としては、エデト酸ナトリウム、チオ硫酸ナトリウム、亜硫酸ナトリウム、塩化ナトリウム、乳酸カルシウム、ラノリン、トリアセチン、ヒマシ油、硫酸マグネシウム等が挙げられる。 Stabilizers include sodium edetate, sodium thiosulfate, sodium sulfite, sodium chloride, calcium lactate, lanolin, triacetin, castor oil, magnesium sulfate and the like.
 矯味剤としては、チャエキス、チャ乾留液、プロポリスエキス、グルタミン酸ナトリウム等が挙げられる。 Examples of the corrigent include tea extract, tea dry distillation liquid, propolis extract, and sodium glutamate.
 収れん剤としては、重曹、乳酸アルミニウム等が挙げられる。 Examples of astringents include baking soda and aluminum lactate.
 増粘剤として、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシメチルエチルセルロース等のセルロース誘導体、キサンタンガム、ローカストビンガム、カラギーナン、トラガカントガム、カラヤガム、アラビアガム、ジェランガム等のガム類、ポリビニルアルコール、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ポリビニルピロリドン等の合成粘結剤、増粘性シリカ、アルミニウムシリカゲル、ビーガム等の無機粘結剤、アルギン酸ナトリウム、ペクチン、寒天、ゼラチン、大豆多糖類、コンドロイチン硫酸ナトリウム、ヒアルロン酸ナトリウム等を添加することも可能である。これらの増粘剤は、単独または2種以上を組み合わせて配合することができる。増粘剤の通常配合量は0.01~20重量%である。 As thickening agents, cellulose derivatives such as hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxymethylethylcellulose, xanthan gum, locust bin gum, carrageenan, tragacanth gum, gums such as karaya gum, gum arabic, gellan gum, polyvinyl alcohol, sodium polyacrylate, carboxy Add synthetic binders such as vinyl polymer and polyvinylpyrrolidone, inorganic binders such as thickening silica, aluminum silica gel, and bee gum, sodium alginate, pectin, agar, gelatin, soybean polysaccharide, sodium chondroitin sulfate, sodium hyaluronate, etc. It is also possible to do. These thickeners can be blended alone or in combination of two or more. The normal blending amount of the thickener is 0.01 to 20% by weight.
 他の薬効剤としては、フッ化ナトリウム、モノフルオロリン酸ナトリウム、フッ化第一錫等のフッ素化合物;デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ、溶菌酵素(リテックエンザイム)等の酵素;トラネキサム酸、ε-アミノカプロン酸、アルミニウムクロルヒドロキシアラントイン、アラントイン、ジヒドロコレステロール、グリチルリチン酸類、グリチルレチン酸、ビサボロール、イソプロピルメチルフェノール、グリセロリン酸、クロロフィル、グルコン酸銅、塩化ナトリウム、水溶性無機リン酸化合物、クロルヘキシジン塩類、トリクロサン、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム;酢酸-dl-α-トコフェロール、酢酸ピリドキシン、アスコルビン酸またはその塩等のビタミン類;アロエ、イチョウ葉、アガリクス、ウーロン茶、カミツレ、カリン、ギムネマ、クマザサ、甜茶、杜仲茶、ドクダミ、ハトムギ、メグスリノキ、ヨモギ、緑茶、ルイボス、レモンバーム、ローズマリー、クラブミン、ラカンカ、シソ、クランベリー、ノコギリソウ、エルダー、リコリス、ハッカ、ユーカリ、ガラナ、カンゾウ、ボダイジュ、ホップ、カカオ、クワ葉、タイム、オウゴン等の植物抽出物等が挙げられる。これらの薬効剤は、単独または2種以上を組み合わせて配合することができる。 Other medicinal agents include: fluorine compounds such as sodium fluoride, sodium monofluorophosphate, stannous fluoride; enzymes such as dextranase, mutanase, amylase, protease, lytic enzyme (Litech Enzyme); tranexamic acid, ε-aminocaproic acid, aluminum chlorohydroxy allantoin, allantoin, dihydrocholesterol, glycyrrhizic acid, glycyrrhetinic acid, bisabolol, isopropylmethylphenol, glycerophosphoric acid, chlorophyll, copper gluconate, sodium chloride, water-soluble inorganic phosphate compound, chlorhexidine salts, triclosan , Cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride; vitamins such as acetic acid-dl-α-tocopherol, pyridoxine acetate, ascorbic acid or salts thereof Aloe, Ginkgo biloba, Agaricus, Oolong tea, Chamomile, Karin, Gymnema, Kumazasa, Tocha tea, Tochu tea, Dokudami, Scallop, Muglinoki, Mugwort, Green tea, Rooibos, Lemon balm, Rosemary, Crabmin, Lacanca, Perilla, Cranberry , Plant extracts such as yarrow, elder, licorice, mint, eucalyptus, guarana, licorice, bodaige, hops, cacao, mulberry leaves, thyme, and ogon. These medicinal agents can be blended alone or in combination of two or more.
 また、その他の基剤として、アルコール類、シリコン、アパタイト、白色ワセリン、パラフィン、流動パラフィン、マイクロクリスタリンワックス、スクワラン等を添加することも可能である。 As other bases, alcohols, silicon, apatite, white petrolatum, paraffin, liquid paraffin, microcrystalline wax, squalane and the like can be added.
 なお、これら任意成分の配合量は、本発明の効果を妨げない程度で、通常の口腔用組成物に配合されている程度の量とすればよい。 In addition, what is necessary is just to let the compounding quantity of these arbitrary components be the quantity of the grade mix | blended with the normal composition for oral cavity, as long as the effect of this invention is not prevented.
 本発明に係る口腔用組成物は、水分含有量が少ない口腔用組成物であることが好ましい。水分含有量が多いと、乳酸菌が短期間で死滅してしまう恐れがあり、この場合口腔用組成物の一般的消費期間を通じた効果の持続は望めないからである。なお、水分含有量が少ない口腔用組成物は、増粘剤を配合しても保形性が望めないことが多く、またさらに、苦味、えぐ味など味に難がある場合が多い。しかし、本発明に係る口腔用組成物は、水分含有量が少なくとも、保形性が良好であり、苦み、えぐ味も改善されるものである。水分含有量が少ない口腔用組成物とは、口腔用組成物全体に対する水の含有量が0~10重量%のものが好ましく、0~8重量%のものがより好ましい。水分含有量は第十五改正日本薬局方の2.48水分測定法(カールフィッシャー法)に記載の容量滴定法により測定することができる。 The oral composition according to the present invention is preferably an oral composition having a low water content. If the water content is high, the lactic acid bacteria may be killed in a short period of time, and in this case, it is not possible to maintain the effect throughout the general consumption period of the oral composition. In addition, oral compositions with a low water content often cannot have shape retention even when a thickener is blended, and furthermore, there are many cases where the taste such as bitterness and gummy taste is difficult. However, the composition for oral cavity according to the present invention has at least a water content, good shape retention, and improved bitterness and taste. The oral composition having a low water content preferably has a water content of 0 to 10% by weight, more preferably 0 to 8% by weight, based on the whole oral composition. The water content can be measured by a volumetric titration method described in 2.48 moisture measurement method (Karl Fischer method) of the 15th revision Japanese Pharmacopoeia.
 以下、本発明を具体的に説明するが、本発明は下記実施例に限定されるものではない。なお、各例中の配合量は、特に断りがない限り重量%を示す。 Hereinafter, the present invention will be specifically described, but the present invention is not limited to the following examples. In addition, the compounding quantity in each example shows weight% unless there is particular notice.
<組成物の調製>
 常法に従い、下記表1、表2及び表3に記載の組成の通り、各組成物(各実施例及び各比較例)を製造した。
<Preparation of composition>
According to a conventional method, each composition (each example and each comparative example) was produced according to the composition described in Table 1, Table 2, and Table 3 below.
<組成物の性能評価>
 各例において製造した組成物の、菌の安定性、保形性、曳糸性、味(苦味、えぐ味)、及び灼熱感を評価した。実施例1~11及び比較例1~9については菌の安定性、保型性、曵糸性、及び味について評価し、実施例12~14については灼熱感、味、菌の安定性について評価した。
<Performance evaluation of composition>
The composition produced in each example was evaluated for bacterial stability, shape retention, stringiness, taste (bitterness, umami), and burning sensation. Examples 1 to 11 and Comparative Examples 1 to 9 were evaluated for fungus stability, shape retention, stringiness, and taste, and Examples 12 to 14 were evaluated for burning feeling, taste, and fungus stability. did.
菌の安定性
 製造した各組成物を、40℃で放置し1ヵ月後の乳酸菌生菌数を測定した。具体的には、一ヶ月後、製剤1gをMRS液体培地に攪拌・希釈後、同寒天培地に塗抹し、37℃で48時間嫌気培養したものの、生菌数をカウントした。評価基準は以下の通りである。
   ○:生菌数の対数で1以下の減少
   △:   〃   1より大きく2未満の減少
   ×:   〃   2以上の減少
Stability of bacteria Each composition produced was allowed to stand at 40 ° C., and the number of viable lactic acid bacteria after one month was measured. Specifically, 1 month later, 1 g of the preparation was stirred and diluted in an MRS liquid medium, smeared on the same agar medium, and anaerobically cultured at 37 ° C. for 48 hours, but the number of viable bacteria was counted. The evaluation criteria are as follows.
○: Logarithm of viable cell count less than 1 △: Decrease greater than 1 and less than 2 ×: Decrease greater than 2
保形性
 製造した各組成物をチューブに充填し、40℃(高温)及び5℃(低温)で1カ月間放置した。その後、チューブから全て絞り出し、保形性について目視にて下記の基準により、評価を行った。評価基準は以下の通りである。
   ○:絞り出した形を5分以上保持している
   △:絞り出し時は形を保持しているが、5分未満で形がなくなる
   ×:絞り出し時から全く保形性がない
Each composition prepared for shape retention was filled into a tube and left at 40 ° C. (high temperature) and 5 ° C. (low temperature) for 1 month. Thereafter, all the tubes were squeezed out, and the shape retention was visually evaluated according to the following criteria. The evaluation criteria are as follows.
○: The squeezed shape is retained for 5 minutes or longer. △: The shape is retained during squeezing, but the shape disappears in less than 5 minutes. ×: There is no shape retention at the time of squeezing.
曳糸性
 製造した各組成物を容器にとり、25℃に加温した後、直径16mmの金属球の下部1/2をその組成物中に浸けた状態から、金属球を一定速度(1000mm/分)で上昇させ、金属球に付着した組成物が切れた時点までの上昇距離を計測し、曵糸性を評価した。評価基準は以下の通りである。
   ○:曵糸性が非常に良いもの(上昇距離が36mm未満)
   △:曵糸性が良いもの(上昇距離が36mm以上40mm未満)
   ×:曵糸性が悪いもの(上昇距離が40mm以上)
   -:測定不能のもの
Takes each composition spinnability produced container, after warming to 25 ° C., from the state immersed the lower half of the metal balls having a diameter of 16mm in the composition, a constant speed (1000 mm / min metal ball ), And measured the distance to rise up to the point when the composition adhering to the metal spheres was cut to evaluate the spinnability. The evaluation criteria are as follows.
○: Very good spinnability (rising distance is less than 36 mm)
Δ: Good spinnability (rising distance is 36 mm or more and less than 40 mm)
×: Poor stringiness (rising distance is 40 mm or more)
-: Unmeasurable
味(苦み、えぐ味)
 製造した各組成物をハブラシに約0.5gとり通常の方法で使用し、下記の評価基準で専門のパネリスト5名を対象に官能評価を実施した。評価基準は以下の通りである。
   ○:苦味、えぐ味は全くない
   △:   〃   ややある
   ×:   〃   かなり強い
Taste (bitterness, delicious taste)
About 0.5 g of each produced composition was taken in a toothbrush and used in a normal manner, and sensory evaluation was conducted on five expert panelists based on the following evaluation criteria. The evaluation criteria are as follows.
○: No bitterness, no umami taste △: 〃 Somewhat ×: 〃 Very strong
灼熱感(温熱感)
 製造した各組成物をハブラシに約0.5gとり、通常の方法で使用し、下記の評価基準で専門のパネリスト5名を対象に官能評価を実施した。評価基準は以下の通りである。
   ◎:灼熱感を全く感じない
   ○:灼熱感を殆ど感じない
   △:灼熱感をやや感じる
   ×:灼熱感をかなり感じる
Burning feeling (heat feeling)
About 0.5 g of each produced composition was taken in a toothbrush and used in a normal manner, and sensory evaluation was carried out on five professional panelists based on the following evaluation criteria. The evaluation criteria are as follows.
◎: Feeling no burning at all ○: Feeling little burning △: Feeling a little burning sensation: Feeling a little burning
 以下に、組成物調製時の配合量及び組成物の性能評価の結果を記載した表を示す。なお、表中の成分についての数値は、その配合量を重量%で表したものである。また、総合評価は、×、△、○、◎の4段階評価で行った。 The table below shows the blending amount at the time of preparing the composition and the results of the performance evaluation of the composition. In addition, the numerical value about the component in a table | surface represents the compounding quantity in weight%. Moreover, comprehensive evaluation was performed by four-step evaluation of x, (triangle | delta), (circle), and (double-circle).
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
 表1及び表2の各実施例に示すとおり、1,3-ブチレングリコール及びヒドロキシエチルセルロースを配合した組成物の乳酸菌の安定性は良好であり、保形性を有し、曵糸性は好適であり、味も改善されることが確認できた。また、表1の実施例の中でも実施例4及び5は全ての評価項目で優れており、1,3-ブチレングリコール、プロピレングリコール及び/又はポリエチレングリコールの合計量が45~70重量%、かつ、1,3-ブチレングリコール/プロピレングリコール(重量比)が1~6の範囲内になるよう配合することで、味がさらに改善されることもわかった。 As shown in each example of Table 1 and Table 2, the composition containing 1,3-butylene glycol and hydroxyethyl cellulose has good stability of lactic acid bacteria, shape retention, and good spinnability. It was confirmed that the taste was improved. Among the examples in Table 1, Examples 4 and 5 are excellent in all evaluation items, and the total amount of 1,3-butylene glycol, propylene glycol and / or polyethylene glycol is 45 to 70% by weight, and It was also found that the taste was further improved by blending 1,3-butylene glycol / propylene glycol (weight ratio) in the range of 1-6.
 表1比較例1や表2比較例8及び9から、グリセリンが多く配合された組成物においては、乳酸菌の安定性は非常に悪いものであることが確認された。 From Table 1 Comparative Example 1 and Table 2 Comparative Examples 8 and 9, it was confirmed that the stability of lactic acid bacteria was very poor in a composition containing a large amount of glycerin.
 表1比較例5~7から、ヒドロキシエチルセルロースの代わりに、ヒドロキシプロピルセルロール、カルボキシメチルセルロース、カラギーナンを用いても、保形性が悪い、あるいは曵糸性が不良であることも確認された。 From Table 1 Comparative Examples 5 to 7, it was confirmed that even when hydroxypropylcellulose, carboxymethylcellulose, and carrageenan were used instead of hydroxyethylcellulose, the shape retention was poor or the spinnability was poor.
 また、実施例12~14は、本願の口腔用組成物の味をさらに改善するために、それぞれソルビトール、パラチニット、グリセリンを用いた例である。表3に示すとおり、いずれも味及び菌の安定性は良好あるいは悪くないが、灼熱感については糖アルコールであるソルビトール、パラチニットを用いた組成物の方が、グリセリンを用いた組成物よりも、大幅に改善された。このことから、味を改善するために用いられる物質のなかでも、糖アルコールは本願に係る口腔用組成物の灼熱感を大幅に改善できることが確認できた。 Examples 12 to 14 are examples in which sorbitol, palatinit, and glycerin were used to further improve the taste of the oral composition of the present application. As shown in Table 3, the taste and the stability of the bacteria are not good or bad, but for the burning sensation, the composition using sugar alcohol sorbitol and paratinite is more than the composition using glycerin, Greatly improved. From this, it was confirmed that among the substances used to improve the taste, sugar alcohol can greatly improve the burning sensation of the oral composition according to the present application.
 以下に、本発明に係る口腔用組成物の処方例を記載する。 Hereinafter, formulation examples of the oral composition according to the present invention will be described.
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004

Claims (6)

  1. 乳酸菌、1,3-ブチレングリコール及びヒドロキシエチルセルロースを含有する口腔用組成物。 An oral composition containing lactic acid bacteria, 1,3-butylene glycol and hydroxyethyl cellulose.
  2. さらに、プロピレングリコール及びポリエチレングリコールからなる群から選ばれるいずれか1種又は2種の湿潤剤を含有する、請求項1に記載の口腔用組成物。 Furthermore, the composition for oral cavity of Claim 1 containing any 1 type or 2 types of wetting agents chosen from the group which consists of propylene glycol and polyethyleneglycol.
  3. 1,3-ブチレングリコールと、プロピレングリコール及び/又はポリエチレングリコールの合計量が35重量%以上である、請求項2に記載の口腔用組成物。 The oral composition according to claim 2, wherein the total amount of 1,3-butylene glycol and propylene glycol and / or polyethylene glycol is 35% by weight or more.
  4. 乳酸菌、1,3-ブチレングリコール、プロピレングリコール及びヒドロキシエチルセルロースを含有し、1,3-ブチレングリコール/プロピレングリコール(重量比)が1以上である、請求項1に記載の口腔用組成物。 The composition for oral cavity according to claim 1, comprising lactic acid bacteria, 1,3-butylene glycol, propylene glycol and hydroxyethyl cellulose, wherein 1,3-butylene glycol / propylene glycol (weight ratio) is 1 or more.
  5. さらに、糖アルコールを含有する、請求項1に記載の口腔用組成物。 Furthermore, the composition for oral cavity of Claim 1 containing sugar alcohol.
  6. さらに、アミノ酸系界面活性剤、アミドベタイン及びアルキルグリコシドからなる群より選択される少なくとも1種の界面活性剤を含有する、請求項1に記載の口腔用組成物。 Furthermore, the composition for oral cavity of Claim 1 containing the at least 1 sort (s) of surfactant selected from the group which consists of an amino acid type surfactant, an amide betaine, and an alkyl glycoside.
PCT/JP2009/050587 2008-01-16 2009-01-16 Composition for oral application WO2009091050A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009550070A JP5404424B2 (en) 2008-01-16 2009-01-16 Oral composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008-007026 2008-01-16
JP2008007026 2008-01-16

Publications (1)

Publication Number Publication Date
WO2009091050A1 true WO2009091050A1 (en) 2009-07-23

Family

ID=40885432

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/050587 WO2009091050A1 (en) 2008-01-16 2009-01-16 Composition for oral application

Country Status (2)

Country Link
JP (1) JP5404424B2 (en)
WO (1) WO2009091050A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011068607A (en) * 2009-09-28 2011-04-07 Sunstar Inc Composition for oral cavity

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11322534A (en) * 1998-05-14 1999-11-24 Kanebo Ltd Ceramide synthesis accelerator
JP2002234825A (en) * 2001-02-08 2002-08-23 Nippon Zettoc Co Ltd Composition for oral cavity application
JP2005298346A (en) * 2004-04-06 2005-10-27 Sangi Co Ltd Oral composition
JP2007131601A (en) * 2005-11-14 2007-05-31 Nippon Zettoc Co Ltd Composition for oral cavity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075448B2 (en) * 1987-03-19 1995-01-25 株式会社ヤクルト本社 Cosmetics
CA2158935A1 (en) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Methods for preserving recombinant viruses
JP4588598B2 (en) * 2004-09-24 2010-12-01 セーレン株式会社 Cell cryopreservation composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11322534A (en) * 1998-05-14 1999-11-24 Kanebo Ltd Ceramide synthesis accelerator
JP2002234825A (en) * 2001-02-08 2002-08-23 Nippon Zettoc Co Ltd Composition for oral cavity application
JP2005298346A (en) * 2004-04-06 2005-10-27 Sangi Co Ltd Oral composition
JP2007131601A (en) * 2005-11-14 2007-05-31 Nippon Zettoc Co Ltd Composition for oral cavity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011068607A (en) * 2009-09-28 2011-04-07 Sunstar Inc Composition for oral cavity

Also Published As

Publication number Publication date
JP5404424B2 (en) 2014-01-29
JPWO2009091050A1 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
ES2441999T3 (en) Oral composition containing crystalline cellulose treated on its surface with a water soluble substance
JP5548969B2 (en) Dentifrice composition
KR100874301B1 (en) Oral Composition
JP2008143825A (en) Tooth paste composition
JP5398102B2 (en) Oral or throat bactericidal composition
JP5233399B2 (en) Oral spray composition and oral preparation
JPH08175947A (en) Composition for oral cavity
JP5493732B2 (en) Oral composition
TW201034697A (en) Dentifrice composition
JP5721973B2 (en) Oral composition
JP5614020B2 (en) Dentifrice composition
JP5570777B2 (en) Oral composition
JPH08175945A (en) Composition for oral cavity
JPH08175946A (en) Composition for oral composition
JP7193788B2 (en) Inhibitor of invasion of periodontal bacteria into gingival tissue cells
JP5404424B2 (en) Oral composition
JP5573120B2 (en) Toothpaste composition
JP2019112375A (en) Oral composition
JP3189549B2 (en) Oral composition
JP7347916B2 (en) dentifrice composition
JP5274826B2 (en) Oral composition
JP3814142B2 (en) Oral composition
WO2016195089A1 (en) Salivation promoter, xerostomia inhibitor, oral cavity moisturizer, and compositions
JP7371351B2 (en) Oral composition
JP7000823B2 (en) Toothpaste composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09701895

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009550070

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09701895

Country of ref document: EP

Kind code of ref document: A1